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Persistence of Polybrominated Biphenyls
(PBB) in Human Post-Mortem Tissue
by Joseph N. Miceli,* David C. Nolan,t
Bernard Marks,* and M. Hariharan**
Polybrominated biphenyl (PBB), a fire retardant, was accidentally substituted for an animal feed sup-
plement in Michigan 10 years ago. This led to widespread livestock contamination and ultimately to
contamination ofvirtually every human residing in the State at that time. In order to evaluate the extent
of PBB persistence and distribution in human tissues 10 years after this accidental poisoning, a study
was conducted on a series of autopsy cases from the Grand Rapids ("high" exposure) area of the State.
No attempt was made to relate cause of death to PBB exposure or tissue concentration.
Samples of 196 tissues from 15 subjects were analyzed for PBB content, and levels were determined by
measurement of the hexabromobiphenyl peak using electron capture gas chromatography. Only 4 of the
196 samples analyzed did not have PBB concentration above the limit of detection (0.5 ng/g).
As expected, fat and fat-rich tissue had the highest PBB concentration. Perirenal fat had the highest
mean concentration (475 ng/g). Adrenal, atheromatus aorta and thymus had mean concentrations about
half that of perirenal fat; all other tissues had mean concentrations one-tenth or less of perirenal fat.
The results document that PBB is still present in human tissue and that PBB was distributed in all
tissues examined. The PBB fat elimination half-time was estimated to be at least 7.8 years. If this is
approximately correct, PBB will persist in tissues throughout the lifetime of humans so contaminated.
Introduction
Ten years ago in Michigan, Firemaster BP-6, a com-
mercial fire retardant composed of a mixture of poly-
brominated biphenyls (PBB), was accidentally
substituted for Nutrimaster, magnesium oxide for use
in animal feed as a supplement. It has been estimated
that one to two tons ofPBB was erroneously mixed into
animal feed (1). More than 90% ofthe human population
(2) residing in Michigan at that time eventually was
exposed toPBB-contaminated meat and dairy products.
In the years following this mishap, studies conducted
in animals have demonstrated that PBB may be hepa-
totoxic, neurotoxic, immunotoxic, and carcinogenic (3-
7). Since PBB is structurally similar to polychlorinated
biphenyl (PCB), it is known that PBB would be highly
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lipid-soluble, highly persistent in the organism, and
highly resistant to biotransformation. Miceli and Marks
(8) have demonstrated body-wide PBB distribution and
long-term persistence of PBB in body tissue of rats.
Indeed, theycalculated thatPBB would notbeexpected
to be eliminated during the animal's lifetime.
PBB concentrations havebeenreportedinhumanadi-
pose tissue (9,10), blood (11,12), breast milk (13), and
serum (14). The purpose ofthis report, an extension of
ourprevious studies (8), is to provide information about
PBB distribution in human tissues and document its
persistence in the body ten years after the initial
contamination.
Materials and Methods
Specimens
Autopsied tissue samples (approximately 5 g) were
obtained from subjects in the Grand Rapids area. The
population of this area had previously been shown to
have been exposed to relatively large amounts of PBB
via the diet. Criteria for inclusion in the study were: (a)
death was due to natural causes or accident (drug-re-
lated deaths were not included) and the subject was
scheduled for autopsy, (b) a history ofresidency in theMICELI ET AL.
area during 1973, and (c) informed consent obtained
from next of kin. Where possible, the following tissues
were obtained from each of the 15 study subjects: ad-
renal, aorta, brain, left ventricle of the heart, kidney
cortex and medulla, liver, lung, pancreas, perirenal fat,
skeletal muscle, spleen, thymus, and thyroid. All sam-
ples were taken at autopsy and placed in PBB-free glass
storage vials. The samples were stored frozen (-70°C)
until analysis. Prior to analysis, all readily dissectable
fatty tissue was removed from the specimens except,
of course, for perirenal fat tissue. Samples were ana-
lyzed in order of receipt with all tissues of one subject
completely analyzed before analysis ofthe next subject
was started.
Quantitation of PBB
Hexane, isooctane, and petroleum ether were glass-
distilled pesticide grade (Burdick and Jackson, Muske-
gon, MI). 60-100 mesh Florisil, PR grade, was obtained
from the Floridin Co., Pittsburgh, PA; anhydrous so-
dium sulfate was obtained from Baker Chemical Co.,
Phillipsburg, NJ; acid-washed and ignited sand from
Mallinckrodt, St. Louis, MO; and Firemaster BP-6 was
from the FDA, Detroit, MI. All other chemicals and
reagents wre reagent grade.
A Perkin-Elmer Sigma 1 gas chromatograph equipped
with a 63Ni electron capture detector, interfaced to a
Perkin-Elmer Sigma 10datastation (Perkin-Elmer Cor-
poration, Norwalk, CT) was used to quantitate PBB.
The data system integrated the area under the peaks
and provided aprint-out ofthe concentration ofthe PBB
isomers. The 1.8 m x 44 mm i.d. glass column was
packed with 2% OV-1 on Gas Chrom Q (Supelco, Bel-
fonte, PA). The carrier gas was argon-methane (95:5),
and the flow rate was 50 mL/min. Prior to use, the
column was conditioned for 24 hr at 270°C with carrier
gas flowing. During chromatography the column tem-
perature was 245°C, the injector temperature was 260°C,
and the detector temperature was 320°C.
Extraction of PBB from Tissue
A modification of the procedures (15,16) previously
used in our labortories is outlined here. Approximately
0.5 g of wet tissue was weighed and transferred to a
150-mL stainless steel beaker. The tissue was then
ground with 5 g of sand and 5 g of anhydrous sodium
sulfate, using a stainless steel rod. After the addition
of20 mL ofhexane to thebeaker, the beaker was warmed
for 5 min in a water bath maintained at 70°C. The so-
lution/slurry was filtered through Whatman No. 1 filter
paper into a 35-mL test tube. This extraction procedure
was repeated four times. At the end ofeach extraction,
the hexane was evaporated under nitrogen at 70°C so
that all of the extracts were concentrated in the same
test tube. The funnel and filter paper were also rinsed
an additional two times and these washings were added
to the same tube and combined with the concentrated
extracts. The entire extraction volume (110 mL) was
concentrated to approximately 1 mL.
The concentrated extract was chromatographed on a
30 x 0.6 cm glass column containing 3.5 g Florisil. The
top of the column was packed with a 2-cm length of
anhydrous granular sodium sulfate. The column was
preconditioned by washing with 10 mL hexane; the tis-
sue extract was then added. The test tube was rinsed
four times with 1 mL of hexane, the washes were se-
quentially added to the column, and chromatography
was conducted with hexane as the mobile phase. The
filtrate (12-15 mL) was collected in a clean 10 x 165
mm test tube, evaporated to dryness at 70°C under
nitrogen, and dissolved in a known volume of hexane
(2-10 mL, depending on amount of residue and initial
sample weight); a 2 ,uL aliquot was injected onto the
gas chromatograph column.
Quantitation of PBB was based on the amount ofthe
2,4,5,2',4',5'-hexabromobiphenyl peak (the most abun-
dant component of Firemaster BP-6). A standard PBB
curve was constructed of PBB concentration (ng/mL)
versus area under the hexabromobiphenyl peak. The
curve was linear from 0.5 to 1000 ng/mL PBB. Samples
that had a concentration initially detennined to be higher
than 1000 ng/mL were appropriately diluted with hex-
ane and re-analyzed. A prepared control was also ana-
lyzed after every 10 samples to assure the quality control
of the procedure.
Results
A summary of pertinent subject information is pre-
sented in Table 1. The ages ranged from 18 to 84 years,
with seven females and eight males. No attempt was
made to correlate cause ofdeath with PBB exposure or
PBB tissue content. The concentration ofPBB found in
each tissue is presented in Table 2. The units were
nanograms per gram of tissue, wet weight. Individual
specimens not received are indicated by a dash. This
information is also presented graphically in Figure 1.
Quality control results are listed in Table 3. Pooled serum
standards were prepared to give a final concentration
Table 1. Subjects used in PBB study.
No. Sex Age Cause of death County ofresidence
1 F 29 Pulmonary edema Kent
2 M 25 Not known Kent
3 F 72 Cerebral accident Kent
4 F 37 Ruptured spleen Kent
5 M 65 Exanguination Muskegon
6 M 77 Acute M.I. Kent
7 M 69 Abdominal hemorrhage Kent
8 F 77 Carcinoma of the brain Manistee
9 M 84 Acute M.I. Ottawa
10 M 77 Acute MI. Kent
11 F 18 CO poisoning Kent
12 M 59 Bilateral pneumonia Ogemaw
13 F 71 Hepatoma Manistee
14 F 57 Cardiac failure Kent
15 M 82 M.I. Kent
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Table 2. PBB post-mortem study.
PBB in tissue, ng/g wet weight
Subject Heart Kidney Renal Skeletal
no. Adrenal Aorta Brain 1. vent. Cortex Medulla Liver Lung Pancreas fat muscle Spleen Thymus Thyroid
1 40 2 6 2 4 9 2 4 80 8 3 3
2 407 118 1 15 4 15 17 2 43 457 10 9 295 9
3 242 247 16 21 18 61 0 63 51 320 42 2 80
4 148 294 103 36 32 30 147 73 653 430 84 123
5 43 18 3 4 3 6 39 4 135 134 7 1 5
6 98 64 24 126 53 77 104 14 130 110 45 64 29 12
7 35 6 1 52 5 6 5 2 9 32 2 2 0 5
8 868 1011 142 233 61 100 259 93 188 1650 22 69
9 75 16 15 6 2 59 6 158 94 11 0 - 12
10 110 285 110 95 81 31 62 170 1110 57 312 40
11 602 107 0 21 29 38 37 11 148 607 33 15 617 41
12 196 29 11 4 17 31 30 80 92 322 13 4 30 22
13 17 44 9 4 2 3 22 4 20 205 14 2 6
14 48 - 5 6 10 5 15 4 17 167 8 4 8
15 850 514 13 37 42 67 143 43 146 1390 53 36 37
Mean 265 216 27 46 25 35 61 31 131 475 27 43 243 22
±SEM 80 77 12 16 7 9 18 9 41 131 6 21 140 6
Range 17-850 6-1011 1-103 4-233 2-95 2-100 0-259 2-93 4-653 32-1650 2-84 0-312 29-617 3-80
Tissue/
renal fat:
mean ratio 0.56 0.45 0.06 0.10 0.05 0.07 0.15 0.07 0.28 1.0 0.06 0.09 0.51 0.06
Tble 3. PBB quality control analysis
Sample no. Concentration, ng/mL
1 26.8
2 33.4
3 27.2
4 31.2
5 29.7
6 27.4
7 30.8
8 27.9
9 26.5
10 28.2
11 26.1
12 32.2
13 30.5
14 32.0
15 30.7
16 24.8
17 24.9
18 31.9
19 27.0
20 29.3
21 28.0
22 33.0
23 25.4
24 27.6
25 27.3
26 25.6
27 32.5
28 26.4
Mean 28.73
SD 2.65
SEM 0.50
of 30 ng/mL with an analytically determined mean +
S.D. of 28.75 + 2.65. These quality control samples
related to reproducibility of the assay but cannot be
directly related to recovery from the tissue samples. It
should also be pointed out that there is no available
information concerning recovery of PBB from tissues
studied in this report using the described extraction
technique. Since PBB is only moderately soluble in hex-
ane, the values reported here are probably lower than
what is actually present.
Renal fat, as expected, had the highest single PBB
concentration (1650 ng/g) as well as the highest mean
tissue concentration (475 ng/g). The other tissues can
be grouped into three classes on the basis of PBB con-
centration relative to that of fat: high (ratios of 0.45-
0.56; adrenal, atheromatus aorta, and thymus), medium
(ratios of 0.1-0.28; pancreas, liver, left ventricle of the
heart), and low (ratios of 0.02 to 0.09; kidney, lung,
brain, skeletal muscle, thyroid and nonatheromatus
aorta).
Discussion
The data presented here document, qualitatively, the
persistence ofPBB in human tissue for ten years. They
also indicate that PBB is not confined to fat or fat-rich
tissue but also appears to be distributed throughout the
entire human body. As mentioned previously, no at-
tempt was made to correlate PBB levels with cause of
death or reported adverse health in each subject. In-
deed, the question ofpotential longtermadverse health
effects associated with PBB remains unanswered.
It is ofinterest to speculate about the time course of
PBB elimination from fat samples. This speculation is
possible by comparing the data in our study with data
obtained in an earlier study (2). The earlier study was
conducted in 1978 on materials from live subjects, as
compared to the present post-mortem study. The adi-
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FIGURE 1. PBB concentrations (ng/g wet weight) in analyzed tissues. The top of the bar indicates the mean value + SEM, the asterisks
denote the range of values determined for each tissue, and the number of each individual tissue analyzed is within each bar.
posetissue samples obtained in ourstudy were obtained
fromthe perirenal areawhereas the adipose tissue sam-
ples ofthe previous study were obtained primarily from
the gluteal and stomach areas. Unfortunately, there is
no information about PBB concentration relationships
in adipose tissue obtained from different sites of the
body. For simplicity, we have assumed a 1:1 PBB con-
centration correspondence between these fatty tissue
sources.
The mean statewide adipose PBB concentration re-
ported (2) for 844 individual tissue sample analyses was
400 ng/g. The mean perirenal adipose PBB level re-
ported in the present study was 475 ng/g. Ifthese two
values are compared, there is an apparent increase in
PBB adipose tissue concentration in post-mortem sam-
ples. This could be due to a shift of PBB from other
tissues to fat as we observed in rats (8). However, due
to the wide range of PBB values observed in the pre-
vious study (2) and in our study, the difference of the
mean is probably not significant and at best it appears
that there was no major decline of PBB fat concentra-
tion. It is also likely that an inappropriate comparison
ofthe mean data lead to these results, probably due to
an inappropriate population comparison.
Most, but not all, ofthe residents in our study had a
historyofresidencyinthe Grand Rapids area. This area
encompassed both Kent and Muskegon Counties and is
in the same location as the Muskegon County area of
the previous study (2). This area constituted a "high"
exposure area. Although a mean value from that area
was not reported from that study, a median PBB value
in adipose tissue was reported as 500 ng/g. The median
PBB concentration in perirenal fat from our study was
320 ng/g tissue. Therefore, comparison of these num-
bers allows one to make an approximate estimation of
the PBB adipose elimination half time (t½). It must be
cautioned, however, that the following discussion is
speculation due to the large number of asdsumptions.
If one assumes that the initial median PBB adipose
concentration was 500 ng/g approximately five years
afterthepoisoningoccurredandthe secondmedianPBB
adipose concentration ws 320 ng/g approximately ten
years after the poisoning occurred, then an estimated
PBB adipose t½) of 7.8 years can be calculated. This is
substantially longerthanthe previously suggested PBB
elimination half-time of ten months (17). Indeed, that
report contains no data at all concerningthe t½). We are
aware of no evidence documenting or supporting such
a short half-time. If the 7.8 year estimate is approxi-
mately correct, it will take nine half-lives (70.2 years)
for PBB spontaneously to reach a fat concentration of
1 ng/g. Support for this estimated half-life is provided
by Tuey and Matthews (18). Using the pharmacokinetic
data obtained from rats, these authors calculated an
estimated body burden half-time in man of 6.5 years.
That prediction is close to the estimation presented in
this report.
It would be of importance to continue to obtain such
data so that greater reliability in the median values can
be obtained. It would also be ofinterest and importance
to determine PBB concentrations in residents from a
low exposure area and in individuals that have moved
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into the State after the initial poisoning. This would
determine ifPBB is still entering or present in the food
chain. The currently accepted view is that PBB no longer
is entering the food chain. This, however, has never
been documented.
This work was supported in part by the Michigan Department of
Health.
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